ATPC Agape ATP Corp

ATPC financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1713210 Exchange: Nasdaq SIC: 8000 (Services-Health Services) Latest filing: 10-Q filed Aug 14, 2026 Data checked: Oct 21, 2026
Showing 3 of 10 annual and 0 of 34 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$5.35M (Dec 2025)
Industry (SIC)
8000 Services-Health Services
Incorporated
NV
Fiscal Year End
December (1231)
Phone
(603) 27325716
EIN
364838886
Headquarters
KUALA LUMPUR, N8, 58100
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$1.15M
Net Income
$-1.14M
Total Assets
$25.03M
Total Equity
$22.05M
Total Debt
-
Free Cash Flow
-
Ratios
Gross Margin
68.4%
Operating Margin
-272.7%
Net Margin
-98.5%
Return on Equity
-5.1%
Return on Assets
-4.5%
Current Ratio
8.45x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Agape ATP Corp generated $1.52M of revenue in fiscal 2025, with net loss of $2.28M and an operating cash outflow of $2.41M. The $1.52M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Revenue was 15.2% above fiscal 2024 revenue of $1.32M, marking a year-over-year increase. The company reported diluted EPS of -$2.85, adding a shareholder-level measure to the absolute income figures considered below. The diluted weighted-average share count was 801.08K, linking total earnings with the per-share result received by shareholders. Compared with 77.84K diluted shares in fiscal 2024, the current 801.08K base was 929.2% higher. The company employed $24.59M of total assets, the balance-sheet base supporting its current operating and cash-flow results. Revenue equaled 0.06x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Gross profit was $838.27K, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross profit represented 55.0% of revenue, showing how much of the top line remained after direct costs. Operations produced a $3.26M operating loss before non-operating and tax effects. The operating loss equaled 213.7% of revenue, showing the scale of the operating deficit relative to sales. The company ended the period with a net loss of $2.28M, extending the operating result through all remaining items. Measured against revenue, the bottom-line deficit represented 149.6% after all recognized items. EBITDA was negative $3.24M, showing a deficit before interest, taxes, depreciation, and amortization. The pretax result was a loss of $2.31M, establishing the deficit before tax effects. Pretax margin was -151.2%, reflecting a pre-tax loss equal to 151.2% of revenue. Income tax expense totaled $2.29K, providing the reported tax component that separates pretax and after-tax earnings. The loss-to-equity relationship was 10.2%, placing the bottom-line deficit against shareholder capital. Relative to total assets, the net loss represented 9.3%. Compared with a $2.47M net loss in fiscal 2024, the current loss improved to $2.28M.

Liquidity and Capital Structure

Total assets were $24.59M, supported by $2.17M of liabilities and $22.43M of shareholder equity. Current assets were $24.29M against $2.05M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. At 11.82x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $140.07K, identifying the most liquid reported component available within the broader current-asset balance. Measured only with cash and equivalents, coverage of current liabilities was 6.8%, excluding receivables and other current assets. Equity equaled 91.2% of assets, showing the shareholder-capital layer within the company’s balance sheet. Liabilities represented 8.8% of total assets, quantifying the liability-funded share of the company’s resource base. The cash-to-assets relationship was 0.6%, comparing reported cash and equivalents with the full positive asset balance. Compared with $3.24M in fiscal 2024, the current asset base moved 659.0% and finished higher. Cash and equivalents were 93.1% lower than fiscal 2024 cash of $2.04M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Operating activities used $2.41M of cash, resulting in an operating cash outflow for the year. Cash absorbed by operations decreased from $2.73M in fiscal 2024 to $2.41M.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Agape ATP Corp
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $1.52M $1.32M $1.43M
Cost of Revenue $685.99K $563.60K $494.52K
Gross Profit $838.27K $759.15K $936.57K
OPERATING EXPENSES
SG&A Expense $3.78M $3.13M $2.37M
Operating Income $-3.26M $-2.57M $-2.15M
NON-OPERATING INCOME / EXPENSE
Interest Income $3.42K $67.93K $29.25K
Other Income/Expense $113.81K $29.21K $5.72K
Pretax Income $-2.31M $-2.48M $-2.11M
Income Tax $2.29K $4.93K $3.58K
Net Income $-2.28M $-2.47M $-2.10M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-2.85 $-31.74 $-0.55
Diluted Shares 801.08K 77.84K 3.79M
EBITDA $-3.24M $-2.52M $-2.08M
Depreciation & Amortization $20.19K $52.57K $70.34K
Balance Sheet
ASSETS
Cash & Equivalents $140.07K $2.04M $4.83M
Accounts Receivable $12.32K $53.65K $55.46K
Inventory $27.39K $46.35K $47.91K
Other Current Assets $24.08M $586.17K $215.81K
Current Assets $24.29M $2.78M $5.19M
PP&E (Net) $14.57K $31.46K $77.86K
Intangible Assets $9.47K $13.08K $17.46K
Noncurrent Assets $299.77K $463.33K $559.34K
Total Assets $24.59M $3.24M $5.74M
LIABILITIES
Current Liabilities $2.05M $1.12M $1.07M
Noncurrent Liabilities $110.66K $190.78K $292.09K
Total Liabilities $2.17M $1.31M $1.36M
EQUITY
Common Stock $100 $8 $386
Additional Paid-in Capital $34.27M $11.42M $11.39M
Retained Earnings $-11.80M $-9.52M $-7.05M
Accumulated OCI $-14.69K $27.85K $30.22K
Total Equity $22.43M $1.93M $4.38M
Total Liabilities & Equity $24.59M $3.24M $5.74M
SUPPLEMENTAL
Shares Outstanding 1.00M 79.78K 3.86M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-2.41M $-2.73M $-2.00M
Capital Expenditures - - -
Cash from Investing $-23.00M $-50.05K $-17.25K
Cash from Financing $23.50M $-11.86K $5.40M
Free Cash Flow - - -
Beginning Cash (CFS) $2.04M $4.83M $1.44M
Net Change in Cash $-1.92M $-2.79M $3.38M
Effect of FX on Cash $15.65K $-4.10K $15.07K
Calculated Ending Cash $140.07K $2.04M $4.83M
Cash per BS $140.07K $2.04M $4.83M
Cash scope difference (CFS − BS) - - -
Cash per CFS $140.07K $2.04M $4.83M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Agape ATP Corp's annual revenue?

Agape ATP Corp reported $1.15M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Agape ATP Corp profitable?

No. Agape ATP Corp reported $-1.14M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.